Gut microbiota modulation and health benefits of various fasting regimens

IF 3.6 Q2 BIOTECHNOLOGY & APPLIED MICROBIOLOGY
Sumel Ashique , Biplab Debnath , Naheed Mojgani , Mohd. Tariq , Tanweer Haider , Eman Shorog , Sabina Yasmin , Anas Islam , Himanshu Sharma , Md Sadique Hussain , Ayush Madan , Tabarak Malik , Mohammad Yousuf Ansari
{"title":"Gut microbiota modulation and health benefits of various fasting regimens","authors":"Sumel Ashique ,&nbsp;Biplab Debnath ,&nbsp;Naheed Mojgani ,&nbsp;Mohd. Tariq ,&nbsp;Tanweer Haider ,&nbsp;Eman Shorog ,&nbsp;Sabina Yasmin ,&nbsp;Anas Islam ,&nbsp;Himanshu Sharma ,&nbsp;Md Sadique Hussain ,&nbsp;Ayush Madan ,&nbsp;Tabarak Malik ,&nbsp;Mohammad Yousuf Ansari","doi":"10.1016/j.crbiot.2025.100311","DOIUrl":null,"url":null,"abstract":"<div><div>Fasting is a diet intervention that has been shown to significantly modulate the gut microbiota, with potential health benefits. This review examines the impact of various fasting regimens, including time-restricted eating (TRE), Ramadan fasting (RF), and long-term fasting, on the composition and function of the gut microbiota in both animal models and human subjects. Studies have shown that fasting can increase microbial diversity, enrich beneficial bacteria such as <em>Faecalibacterium prausnitzii, Roseburia</em> spp.<em>, Akkermansia muciniphila</em>, and other Lachnospiraceae, and enhance the production of short-chain fatty acids (SCFA) such as butyrate. These microbiota changes are associated with improvements in metabolic health markers, including body weight, blood pressure, glucose regulation, and lipid profiles, as well as reduced inflammation. However, the persistence of these effects after fasting varies between studies. Dietary changes during fasting, such as meal timing and composition, play a crucial role in shaping the response of the gut microbiota.Although most studies report beneficial results, heterogeneity in results highlights the need for more research to elucidate the relative contributions of factors such as age, baseline diet, habitual microbiota composition, fasting duration, and caloric content. The mechanistic links between specific microbial metabolites and clinical endpoints remain limited, and evidence for the synergistic effects of probiotics with fasting in humans is inconclusive. Future studies should employ standardized fasting protocols, integrate multi-omics approaches, and extend follow-up periods to determine the durability of microbiota and metabolic shifts. Developing personalized fasting strategies tailored to an individual’s baseline microbiota and metabolic phenotype may optimize the therapeutic potential of fasting for gut and metabolic health.</div></div>","PeriodicalId":52676,"journal":{"name":"Current Research in Biotechnology","volume":"10 ","pages":"Article 100311"},"PeriodicalIF":3.6000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Research in Biotechnology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2590262825000425","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Fasting is a diet intervention that has been shown to significantly modulate the gut microbiota, with potential health benefits. This review examines the impact of various fasting regimens, including time-restricted eating (TRE), Ramadan fasting (RF), and long-term fasting, on the composition and function of the gut microbiota in both animal models and human subjects. Studies have shown that fasting can increase microbial diversity, enrich beneficial bacteria such as Faecalibacterium prausnitzii, Roseburia spp., Akkermansia muciniphila, and other Lachnospiraceae, and enhance the production of short-chain fatty acids (SCFA) such as butyrate. These microbiota changes are associated with improvements in metabolic health markers, including body weight, blood pressure, glucose regulation, and lipid profiles, as well as reduced inflammation. However, the persistence of these effects after fasting varies between studies. Dietary changes during fasting, such as meal timing and composition, play a crucial role in shaping the response of the gut microbiota.Although most studies report beneficial results, heterogeneity in results highlights the need for more research to elucidate the relative contributions of factors such as age, baseline diet, habitual microbiota composition, fasting duration, and caloric content. The mechanistic links between specific microbial metabolites and clinical endpoints remain limited, and evidence for the synergistic effects of probiotics with fasting in humans is inconclusive. Future studies should employ standardized fasting protocols, integrate multi-omics approaches, and extend follow-up periods to determine the durability of microbiota and metabolic shifts. Developing personalized fasting strategies tailored to an individual’s baseline microbiota and metabolic phenotype may optimize the therapeutic potential of fasting for gut and metabolic health.

Abstract Image

肠道菌群调节和各种禁食方案的健康益处
禁食是一种饮食干预,已被证明可以显著调节肠道微生物群,具有潜在的健康益处。本综述研究了各种禁食方案,包括限时饮食(TRE)、斋月禁食(RF)和长期禁食,对动物模型和人类受试者肠道微生物群的组成和功能的影响。研究表明,禁食可以增加微生物多样性,丰富有益菌,如Faecalibacterium prausnitzii, Roseburia spp., Akkermansia muciniphila等毛螺科菌,并促进丁酸盐等短链脂肪酸(SCFA)的产生。这些微生物群的变化与代谢健康指标的改善有关,包括体重、血压、血糖调节和脂质谱,以及炎症的减少。然而,在不同的研究中,禁食后这些影响的持续程度有所不同。禁食期间的饮食变化,如用餐时间和组成,在塑造肠道微生物群的反应中起着至关重要的作用。尽管大多数研究报告了有益的结果,但结果的异质性强调了需要更多的研究来阐明年龄、基线饮食、习惯微生物群组成、禁食时间和热量含量等因素的相对贡献。特定微生物代谢物与临床终点之间的机制联系仍然有限,益生菌与人类禁食的协同作用的证据尚无定论。未来的研究应采用标准化的禁食方案,整合多组学方法,并延长随访时间,以确定微生物群的持久性和代谢变化。根据个体的基线微生物群和代谢表型制定个性化的禁食策略,可能会优化禁食对肠道和代谢健康的治疗潜力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Current Research in Biotechnology
Current Research in Biotechnology Biochemistry, Genetics and Molecular Biology-Biotechnology
CiteScore
6.70
自引率
3.60%
发文量
50
审稿时长
38 days
期刊介绍: Current Research in Biotechnology (CRBIOT) is a new primary research, gold open access journal from Elsevier. CRBIOT publishes original papers, reviews, and short communications (including viewpoints and perspectives) resulting from research in biotechnology and biotech-associated disciplines. Current Research in Biotechnology is a peer-reviewed gold open access (OA) journal and upon acceptance all articles are permanently and freely available. It is a companion to the highly regarded review journal Current Opinion in Biotechnology (2018 CiteScore 8.450) and is part of the Current Opinion and Research (CO+RE) suite of journals. All CO+RE journals leverage the Current Opinion legacy-of editorial excellence, high-impact, and global reach-to ensure they are a widely read resource that is integral to scientists' workflow.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信